Clinical Trials Browser

INDUSTRY × Oligodendroglioma × BID protein, human × Clear all

NCT05561374 2024-11-29

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

Phase 1 Active not recruiting

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma